Clinical trial IPSOC-mamma
Prospective, Non-interventional, non-controlled multicenter observational study to evaluate aspects of pharmaceutical care and the treatment of postmenopausal patients with hormone-receptor positive, HER2-receptor negative, advanced breast cancer treated with everolimus and exemestane
| Cancers | |
|---|---|
| Organ | Breast |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Prospective observational study
|
| Phase | Trial phase 3 |
| Academic trial | Oui |
| Sponsor | UZ-K.U.Leuven |
| BECT Identifier | B322201525429 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02875951 |
| Inclusion criteria | Hormono positif Her2 negatif |
| Last update |